
Will GoodRX Stock Bounce Back?
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Revenue | $17.3B | $16.6B | $15.3B | $15.2B | $15.5B | |
Revenue Growth (YoY) | -2.72% | -4.19% | -8.1% | -0.29% | 1.6% | |
Cost of Revenues | $9.8B | $9.1B | $8.3B | $8.3B | $8.4B | |
Gross Profit | $7.5B | $7.5B | $6.9B | $6.9B | $7B | |
Gross Profit Margin | 43.46% | 45.17% | 45.53% | 45.14% | 45.59% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $6B | $6B | $5.5B | $5.4B | $5.7B | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $6.6B | $6.9B | $6.1B | $5.8B | $6.2B | |
Operating Income | $964.2M | $620.5M | $889.7M | $1.1B | $828.5M | |
Net Interest Expenses | $29.2M | $27M | -- | $10.6M | $22.5M | |
EBT. Incl. Unusual Items | $1.2B | $907.9M | $1.5B | $1.4B | $923.5M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $231.5M | $284.3M | $365.2M | $332.2M | $356.3M | |
Net Income to Company | $1.2B | $907.9M | $1.5B | $1.4B | $923.5M | |
Minority Interest in Earnings | -$261.5M | -$78.7M | -$251.3M | -$269M | -$182.4M | |
Net Income to Common Excl Extra Items | $674M | $544.9M | $851.3M | $803.2M | $384.8M | |
Basic EPS (Cont. Ops) | $0.80 | $0.65 | $1.04 | $0.99 | $0.48 | |
Diluted EPS (Cont. Ops) | $0.80 | $0.65 | $1.04 | $0.99 | $0.47 | |
Weighted Average Basic Share | $840.7M | $833.5M | $821.8M | $809.9M | $809.9M | |
Weighted Average Diluted Share | $840.7M | $833.9M | $821.8M | $809.9M | $809.9M | |
EBITDA | $2B | $1.7B | $2.2B | $2.1B | $1.7B | |
EBIT | $1.2B | $972.1M | $1.5B | $1.5B | $1B | |
Revenue (Reported) | $17.3B | $16.6B | $15.3B | $15.2B | $15.5B | |
Operating Income (Reported) | $964.2M | $620.5M | $889.7M | $1.1B | $828.5M | |
Operating Income (Adjusted) | $1.2B | $972.1M | $1.5B | $1.5B | $1B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $3.9B | $3.6B | $3.4B | $3.4B | $3.6B | |
Revenue Growth (YoY) | -0.87% | -7.18% | -4.96% | -0.84% | -10.49% | |
Cost of Revenues | $2.1B | $2B | $1.9B | $1.8B | $1.9B | |
Gross Profit | $1.7B | $1.6B | $1.5B | $1.5B | $1.7B | |
Gross Profit Margin | 44.42% | 44.72% | 45.4% | 45.59% | 46.46% | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $1.4B | $1.4B | $1.3B | $1.3B | $1.4B | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $1.5B | $1.4B | $1.5B | $1.3B | $1.5B | |
Operating Income | $264.5M | $179.2M | $83.2M | $207.7M | $203.3M | |
Net Interest Expenses | -- | -- | -- | -- | $9.3M | |
EBT. Incl. Unusual Items | $316.9M | $245.4M | $151.9M | $297.6M | $250.9M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $88.9M | $26.6M | $66.1M | $78.1M | $71.3M | |
Net Income to Company | $316.9M | $245.4M | $151.9M | $297.6M | $250.9M | |
Minority Interest in Earnings | -$67.8M | -$69.1M | -$43.4M | -$45M | -$20M | |
Net Income to Common Excl Extra Items | $160.2M | $149.7M | $42.3M | $174.5M | $159.6M | |
Basic EPS (Cont. Ops) | $0.19 | $0.18 | $0.05 | $0.22 | $0.20 | |
Diluted EPS (Cont. Ops) | $0.19 | $0.18 | $0.05 | $0.22 | $0.20 | |
Weighted Average Basic Share | $833.6M | $833.6M | $809.8M | $809.9M | $809.9M | |
Weighted Average Diluted Share | $833.6M | $833.6M | $809.8M | $809.9M | $809.9M | |
EBITDA | $512.9M | $432.8M | $312.6M | $457.4M | $437.6M | |
EBIT | $329.3M | $256.6M | $162.2M | $313.4M | $271.2M | |
Revenue (Reported) | $3.9B | $3.6B | $3.4B | $3.4B | $3.6B | |
Operating Income (Reported) | $264.5M | $179.2M | $83.2M | $207.7M | $203.3M | |
Operating Income (Adjusted) | $329.3M | $256.6M | $162.2M | $313.4M | $271.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $17.3B | $16.3B | $15B | $15.1B | $14.7B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $9.8B | $8.9B | $8.1B | $8.3B | $8B | |
Gross Profit | $7.6B | $7.4B | $6.8B | $6.8B | $6.8B | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $6B | $6B | $5.4B | $5.4B | $5.5B | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $6.6B | $6.8B | $6B | $5.7B | $5.8B | |
Operating Income | $985.4M | $546.9M | $800.6M | $1.2B | $989.6M | |
Net Interest Expenses | $23.7M | $11.6M | -- | -- | -- | |
EBT. Incl. Unusual Items | $1.2B | $846.9M | $1.4B | $1.5B | $1.3B | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $282.2M | $224.8M | $393.2M | $340.7M | $382.4M | |
Net Income to Company | $1.2B | $836.4M | $1.4B | $1.6B | $1.4B | |
Minority Interest in Earnings | -$254.8M | -$85.4M | -$230.8M | -$266.2M | -$218.9M | |
Net Income to Common Excl Extra Items | $645.2M | $536.8M | $740.8M | $921.3M | $730M | |
Basic EPS (Cont. Ops) | $0.78 | $0.64 | $0.91 | $1.14 | $0.90 | |
Diluted EPS (Cont. Ops) | $0.78 | $0.64 | $0.91 | $1.14 | $0.90 | |
Weighted Average Basic Share | ||||||
Weighted Average Diluted Share | ||||||
EBITDA | $2B | $1.6B | $2B | $2.2B | $2B | |
EBIT | $1.3B | $909.5M | $1.4B | $1.6B | $1.4B | |
Revenue (Reported) | $17.3B | $16.3B | $15B | $15.1B | $14.7B | |
Operating Income (Reported) | $985.4M | $546.9M | $800.6M | $1.2B | $989.6M | |
Operating Income (Adjusted) | $1.3B | $909.5M | $1.4B | $1.6B | $1.4B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Revenue | $3.9B | $3.6B | $3.4B | $3.4B | $3.6B | |
Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
Cost of Revenues | $2.1B | $2B | $1.9B | $1.8B | $1.9B | |
Gross Profit | $1.7B | $1.6B | $1.5B | $1.5B | $1.7B | |
Gross Profit Margin | -- | -- | -- | -- | -- | |
R&D Expenses | -- | -- | -- | -- | -- | |
Selling, General & Admin | $1.4B | $1.4B | $1.3B | $1.3B | $1.4B | |
Other Inc / (Exp) | -- | -- | -- | -- | -- | |
Operating Expenses | $1.5B | $1.4B | $1.5B | $1.3B | $1.5B | |
Operating Income | $264.5M | $179.2M | $83.2M | $207.7M | $203.3M | |
Net Interest Expenses | -- | -- | -- | -- | $9.3M | |
EBT. Incl. Unusual Items | $316.9M | $245.4M | $151.9M | $297.6M | $250.9M | |
Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
Income Tax Expense | $88.9M | $26.6M | $66.1M | $78.1M | $71.3M | |
Net Income to Company | $316.9M | $245.4M | $151.9M | $297.6M | $250.9M | |
Minority Interest in Earnings | -$67.8M | -$69.1M | -$43.4M | -$45M | -$20M | |
Net Income to Common Excl Extra Items | $160.2M | $149.7M | $42.3M | $174.5M | $159.6M | |
Basic EPS (Cont. Ops) | $0.19 | $0.18 | $0.05 | $0.22 | $0.20 | |
Diluted EPS (Cont. Ops) | $0.19 | $0.18 | $0.05 | $0.22 | $0.20 | |
Weighted Average Basic Share | $833.6M | $833.6M | $809.8M | $809.9M | $809.9M | |
Weighted Average Diluted Share | $833.6M | $833.6M | $809.8M | $809.9M | $809.9M | |
EBITDA | $512.9M | $432.8M | $312.6M | $457.4M | $437.6M | |
EBIT | $329.3M | $256.6M | $162.2M | $313.4M | $271.2M | |
Revenue (Reported) | $3.9B | $3.6B | $3.4B | $3.4B | $3.6B | |
Operating Income (Reported) | $264.5M | $179.2M | $83.2M | $207.7M | $203.3M | |
Operating Income (Adjusted) | $329.3M | $256.6M | $162.2M | $313.4M | $271.2M |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $1.6B | $1.3B | $671.6M | $931.8M | $755.4M | |
Short Term Investments | $77.1M | $68.7M | $63.9M | $63.4M | $54.6M | |
Accounts Receivable, Net | $3.6B | $3.4B | $3.1B | $3.2B | $3.2B | |
Inventory | $2.1B | $2.1B | $2.2B | $2.3B | $2.3B | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $329.1M | $296.1M | $313.7M | $294.7M | $332M | |
Total Current Assets | $8.4B | $7.2B | $6.8B | $6.8B | $6.6B | |
Property Plant And Equipment | $5.1B | $4.6B | $4.3B | $4.2B | $4.3B | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $2.4B | $2.3B | $2.2B | $2.8B | $3.2B | |
Other Intangibles | $2B | $1.7B | $1.5B | $2.2B | $4.2B | |
Other Long-Term Assets | $205.2M | $215M | $211.3M | $279M | $309.3M | |
Total Assets | $23.8B | $21.5B | $19.4B | $20.3B | $21.4B | |
Accounts Payable | $2.1B | $2B | $2B | $2.2B | $2.3B | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | $1.6B | $1.5B | $1.4B | $1.3B | $1.4B | |
Total Current Liabilities | $7.2B | $5.2B | $4.8B | $4.8B | $4.7B | |
Long-Term Debt | $3.8B | $3.9B | $3.1B | $3.9B | $5B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $13.2B | $11.5B | $9.8B | $10.2B | $11.6B | |
Common Stock | $989.4M | $886.8M | $778.3M | $723.6M | $649.8M | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | $8.1B | $7.8B | $7.5B | $8B | $7.5B | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $2.5B | $2.2B | $2.1B | $2.1B | $2.2B | |
Total Equity | $10.6B | $10B | $9.6B | $10.1B | $9.8B | |
Total Liabilities and Equity | $23.8B | $21.5B | $19.4B | $20.3B | $21.4B | |
Cash and Short Terms | $1.6B | $1.4B | $735.5M | $995.2M | $809.9M | |
Total Debt | $6.2B | $4.8B | $4B | $4.7B | $5.5B |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Cash and Equivalents | $2B | $1.3B | $877M | $999M | $818.8M | |
Short Term Investments | $89.7M | $60.8M | $59.3M | $59.1M | $68.9M | |
Accounts Receivable, Net | $2.7B | $2.5B | $2.5B | $2.7B | $2.8B | |
Inventory | $2.2B | $2.2B | $2.3B | $2.3B | $2.4B | |
Prepaid Expenses | -- | -- | -- | -- | -- | |
Other Current Assets | $319.8M | $289.6M | $338.5M | $375M | $353.1M | |
Total Current Assets | $7.3B | $6.9B | $6.1B | $6.5B | $6.4B | |
Property Plant And Equipment | $4.8B | $4.6B | $4.3B | $4B | $4.5B | |
Long-Term Investments | -- | -- | -- | -- | -- | |
Goodwill | $2.3B | $2.6B | $2.2B | $2.9B | $3.2B | |
Other Intangibles | $1.9B | $1.6B | $1.5B | $2.3B | $4.3B | |
Other Long-Term Assets | $191.7M | $208.2M | $207.6M | $277.9M | $335.2M | |
Total Assets | $22.1B | $20.6B | $18.5B | $19.9B | $21.8B | |
Accounts Payable | $1.8B | $1.7B | $1.7B | $2.1B | $2B | |
Accrued Expenses | -- | -- | -- | -- | -- | |
Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
Current Portion Of Capital Lease Obligations | -- | -- | -- | -- | -- | |
Other Current Liabilities | $1.2B | $1.2B | $1.1B | $1.2B | $1.2B | |
Total Current Liabilities | $6.3B | $4.9B | $4.2B | $4.6B | $5.6B | |
Long-Term Debt | $3.4B | $3.8B | $3.3B | $4.1B | $5B | |
Capital Leases | -- | -- | -- | -- | -- | |
Total Liabilities | $11.8B | $10.8B | $9.3B | $10.2B | $12.5B | |
Common Stock | $925M | $836.1M | $765.9M | $674.2M | $682M | |
Other Common Equity Adj | -- | -- | -- | -- | -- | |
Common Equity | -- | -- | -- | -- | -- | |
Total Preferred Equity | -- | -- | -- | -- | -- | |
Minority Interest, Total | $2.4B | $2.1B | $1.9B | $1.9B | $1.9B | |
Total Equity | $10.2B | $9.8B | $9.2B | $9.6B | $9.3B | |
Total Liabilities and Equity | $22.1B | $20.6B | $18.5B | $19.9B | $21.8B | |
Cash and Short Terms | $2.1B | $1.3B | $936.3M | $1.1B | $887.6M | |
Total Debt | $6.1B | $5.2B | $4.2B | $5B | $6.9B |
Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $1.2B | $907.9M | $1.5B | $1.4B | $923.5M | |
Depreciation & Amoritzation | $769.3M | $739.4M | $659M | $621.7M | $632.6M | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | $35.4M | -$83M | -$64.8M | -$95.3M | -$230.6M | |
Change in Inventories | -$57M | -$185.5M | -$302.8M | -$143M | -$32.3M | |
Cash From Operations | $1.5B | $2B | $1B | $1.4B | $1.6B | |
Capital Expenditures | $871.5M | $786.9M | $755.2M | $811.2M | $1.2B | |
Cash Acquisitions | -$388.8M | $21.6M | $508M | -$962.8M | -$1B | |
Cash From Investing | -$1.1B | -$514.1M | -$79.7M | -$1.6B | -$2.2B | |
Dividends Paid (Ex Special Dividend) | -$518.3M | -$493.8M | -$412.4M | -$409.8M | -$385.4M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $1.8B | $647.1M | $704.4M | $1.9B | $2B | |
Long-Term Debt Repaid | -$998.4M | -$820.3M | -$518.5M | -$844.4M | -$716.6M | |
Repurchase of Common Stock | -$719.8M | -$519.5K | -$383.8M | -$249.5K | -$265M | |
Other Financing Activities | -$53.8M | -$2.4M | $30.1M | -$3.1M | -$63.6M | |
Cash From Financing | -$491.6M | -$1.6B | -$1.3B | $255.9M | $384.2M | |
Beginning Cash (CF) | $1.6B | $1.5B | $1.1B | $627.6M | $868.5M | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | -$33.9M | -$160.1M | -$327.2M | $92.8M | -$187.8M | |
Ending Cash (CF) | $1.5B | $1.4B | $675.3M | $936.5M | $784M | |
Levered Free Cash Flow | $672.8M | $1.2B | $284.4M | $637.2M | $411.5M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $316.9M | $245.4M | $151.9M | $297.6M | $250.9M | |
Depreciation & Amoritzation | $183.6M | $176.2M | $150.4M | $144M | $166.4M | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | $739.1M | $739.5M | $603.2M | $335.2M | $485.9M | |
Change in Inventories | -$132.7M | -$140M | -$119.2M | -$97.9M | -$47.2M | |
Cash From Operations | $347M | $142.4M | $316.9M | $268.7M | $67.2M | |
Capital Expenditures | $178.9M | $154.2M | $219M | $148.2M | $242.4M | |
Cash Acquisitions | $404M | -$397.8M | -$37.9M | -$303.7M | -- | |
Cash From Investing | $214.7M | -$537.9M | -$237.8M | -$440.3M | -$297.8M | |
Dividends Paid (Ex Special Dividend) | -$255.8M | -$233.2M | -$223.8M | -$199.2M | -$188.6M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | $175.8M | $378.5M | $687.1M | -- | |
Long-Term Debt Repaid | -$94.4M | -$172.1M | -$75.7M | -$210.8M | -$164M | |
Repurchase of Common Stock | -$113.3K | -$51.7K | -$60.6K | -$50M | -$52.5K | |
Other Financing Activities | -- | -$25.8K | -- | -$51.7M | -$512.6M | |
Cash From Financing | -$85.6M | $331M | -$65.2M | $234.1M | $382M | |
Beginning Cash (CF) | $1.5B | $1.3B | $666.7M | $885.3M | $777.9M | |
Foreign Exchange Rate Adjustment | $69.4M | $103.4M | $11.2M | $70.9M | -$55.4M | |
Additions / Reductions | $476.2M | -$64.4M | $13.9M | $62.6M | $151.4M | |
Ending Cash (CF) | $2.1B | $1.3B | $884.7M | $1B | $803.5M | |
Levered Free Cash Flow | $168.2M | -$11.7M | $97.8M | $120.5M | -$175.2M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $1.2B | $836.4M | $1.4B | $1.6B | $1.4B | |
Depreciation & Amoritzation | $770M | $732M | $633.2M | $615.3M | $629.2M | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | $73.4M | -$82.6M | -$201.1M | -$363.3M | $585.8M | |
Change in Inventories | -$63.7M | -$192.8M | -$282M | -$121.7M | -$138.5M | |
Cash From Operations | $1.8B | $1.8B | $1.2B | $1.4B | $1.3B | |
Capital Expenditures | $848M | $762.2M | $820.1M | $740.4M | $914.6M | |
Cash Acquisitions | $385.5M | -$780.1M | $867.8M | -$1.2B | -$170.8M | |
Cash From Investing | -$298.6M | -$1.3B | $220.3M | -$1.8B | -$1.1B | |
Dividends Paid (Ex Special Dividend) | -$514.9M | -$471.2M | -$403M | -$385.2M | -$390M | |
Special Dividend Paid | ||||||
Long-Term Debt Issued | $1.1B | $822.9M | $907.1M | $2.2B | $1.7B | |
Long-Term Debt Repaid | -$809M | -$898M | -$422.1M | -$979.5M | -$980.2M | |
Repurchase of Common Stock | -$131.9M | -$457.8K | -$383.8M | -$50.2M | -$173.8M | |
Other Financing Activities | -- | -$2.5M | -- | -$54.7M | -$572.9M | |
Cash From Financing | -$1.1B | -$1.2B | -$1.7B | $555.3M | -$398M | |
Beginning Cash (CF) | -- | -- | -- | -- | -- | |
Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
Additions / Reductions | $443.4M | -$700.8M | -$248.9M | $141.5M | -$125.7M | |
Ending Cash (CF) | -- | -- | -- | -- | -- | |
Levered Free Cash Flow | $962.8M | $1B | $394M | $659.8M | $412.1M |
Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
---|---|---|---|---|---|---|
Net Income to Stockholders | $316.9M | $245.4M | $151.9M | $297.6M | $250.9M | |
Depreciation & Amoritzation | $183.6M | $176.2M | $150.4M | $144M | $166.4M | |
Stock-Based Compensation | -- | -- | -- | -- | -- | |
Change in Accounts Receivable | $739.1M | $739.5M | $603.2M | $335.2M | $485.9M | |
Change in Inventories | -$132.7M | -$140M | -$119.2M | -$97.9M | -$47.2M | |
Cash From Operations | $347M | $142.4M | $316.9M | $268.7M | $67.2M | |
Capital Expenditures | $178.9M | $154.2M | $219M | $148.2M | $242.4M | |
Cash Acquisitions | $404M | -$397.8M | -$37.9M | -$303.7M | -- | |
Cash From Investing | $214.7M | -$537.9M | -$237.8M | -$440.3M | -$297.8M | |
Dividends Paid (Ex Special Dividend) | -$255.8M | -$233.2M | -$223.8M | -$199.2M | -$188.6M | |
Special Dividend Paid | -- | -- | -- | -- | -- | |
Long-Term Debt Issued | -- | $175.8M | $378.5M | $687.1M | -- | |
Long-Term Debt Repaid | -$94.4M | -$172.1M | -$75.7M | -$210.8M | -$164M | |
Repurchase of Common Stock | -$113.3K | -$51.7K | -$60.6K | -$50M | -$52.5K | |
Other Financing Activities | -- | -$25.8K | -- | -$51.7M | -$512.6M | |
Cash From Financing | -$85.6M | $331M | -$65.2M | $234.1M | $382M | |
Beginning Cash (CF) | $1.5B | $1.3B | $666.7M | $885.3M | $777.9M | |
Foreign Exchange Rate Adjustment | $69.4M | $103.4M | $11.2M | $70.9M | -$55.4M | |
Additions / Reductions | $476.2M | -$64.4M | $13.9M | $62.6M | $151.4M | |
Ending Cash (CF) | $2.1B | $1.3B | $884.7M | $1B | $803.5M | |
Levered Free Cash Flow | $168.2M | -$11.7M | $97.8M | $120.5M | -$175.2M |
Signup to receive the latest stock alerts
GoodRX (NASDAQ:GDRX) tracks prescription drug prices and its model was…
Freeport-McMoRan (NYSE:FCX) is among the world’s largest producers of copper…
Levi Strauss (NYSE:LEVI) is among the oldest clothing brands in…
Market Cap: $4.2T
P/E Ratio: 58x
Market Cap: $3.8T
P/E Ratio: 43x
Market Cap: $3.1T
P/E Ratio: 35x
SharpLink Gaming [SBET] is down 2.6% over the past day.
Exodus Movement [EXOD] is down 4.14% over the past day.
Unity Software [U] is up 7.51% over the past day.